Alzheimer’s disease drives up to 70% of dementia cases worldwide, presenting healthcare systems with mounting challenges.
The new unit employs advanced systems that optimize water usage during dialysis treatments, reducing waste without affecting treatment efficacy.
The platform integrates medical devices and health information systems, creating a connected data thread with central monitoring and surveillance workflows that support clinical decision-making across encounters and over time.
Philips’ cloud-enabled offering supports secure remote access to images, simplifies data management at scale, and facilitates enterprise integration and AI-enabled applications across health systems.
The device transmits this data to an artificial intelligence-powered app on the parent’s smartphone, which analyzes the information in real time.
SmartHeart can cut the number of required breath-holds for basic views by up to 75%, making the examination considerably more comfortable for those being scanned.
The system combines Philips’ most advanced detector technology with AI-powered workflows and industry-leading speed, representing a significant advancement in high-acuity imaging.
The company showcased three new angiography platforms—Artis genio, Artis icono.explore, and Artis icono.vision—which harness artificial intelligence to enhance the precision of liver cancer embolization treatments.
Abbott engineered the HERO reader to be 60% lighter than its predecessor, making it practical for daily use and convenient enough for patients to carry during travel.
The proprietary CXLens system delivers patterned ultraviolet light to reshape the cornea while keeping the epithelium—the eye’s protective outer layer—completely intact.